The world's largest generic drugmaker, Teva Pharmaceutical Industries Ltd, has chosen Erez Vigodman to become its President and Chief Executive Officer beginning February 11, Bloomberg reported.
Erez Vigodman
Breaking News
TheMarker, a financial news website, said generic drugmaker Teva Pharmaceutical Industries is set to name Erez Vigodman as its new Chief Executive on January 13 at the JPMorgan Healthcare Conference in San Francisco, Reuters reported.
Subscribe to VCpost newsletter
Most Popular
- IRS Scrambles to Address Huge Gap in Audit Rates Between Black, Other Taxpayers
- Hims & Hers CEO Responds to Backlash After Facing Stock Plunge Over Comments Praising Anti-Israel Protesters
- Americans Brace for Another Round of Higher Housing Costs, NY Fed Survey Shows
- Social Security and Medicare Get Boost From Stronger US Economy, But Funds Expected to Run Short in 2035
- Biden’s Economic Advisor Jared Bernstein Awkwardly Explains How Money Works
- Xi Jinping Urges France to Resist 'New Cold War' Amid EU's Shift Towards US Alliance
- Over 1,000 Denver International Airport Flights Delayed Over Wind Gusts
- EU is Set to Intensify Sanctions Against Russia Amid Report Kremlin Plots Sabotage Attack
